Biosimilars saved Italy €3.1 billion in drug spending over a decade as uptake reached 80% of biologic use, according to the ...
A trial in Italy that's testing Avextra’s cannabis-based medicine for ALS and other neurodegenerative diseases enrolled its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback